Anest. intenziv. Med. 2022;33(6):308-311 | DOI: 10.36290/aim.2022.038

Year 2022 in review - Critical care nephrologyReview Article

Chvojka J.1, 2, 3, 4, 5, Matějovič M.1, 2, 3
1 Jednotka intenzivní péče, I. interní klinika, Lékařská fakulta v Plzni, Univerzita Karlova, Plzeň
2 Jednotka intenzivní péče, I. interní klinika, Fakultní nemocnice v Plzni
3 Biomedicínské centrum, Lékařská fakulta v Plzni, Univerzita Karlova, Plzeň
4 Klinika anesteziologie, resuscitace a intenzivní medicíny, Lékařská fakulta v Plzni, Univerzita Karlova, Plzeň
5 Klinika anesteziologie, resuscitace a intenzivní medicíny, Fakultní nemocnice v Plzni

The intensive care medicine literature continued to resonate with the fading COVID-19 pandemic in 2022. Nevertheless, several interesting scientific publications have appeared in the field of critical care nephrology, the contents of which are worth mentioning. This summary article aims to guide the reader through the most fundamental aspects of nephrotoxicity, acute kidney injury, and extracorporeal purification methods.

Keywords: acute kidney injury, sepsis, nephrotoxicity, extracorporal purification methods.

Received: November 11, 2022; Revised: November 11, 2022; Accepted: November 16, 2022; Published: December 21, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Chvojka J, Matějovič M. Year 2022 in review - Critical care nephrology. Anest. intenziv. Med. 2022;33(6):308-311. doi: 10.36290/aim.2022.038.
Download citation

References

  1. Beneš J, Chvojka J, Karvunidis T, Kletečka J, Máca J, Zatloukal, et al. Rok 2021 v přehledu - Intenzivní medicína. Anest intenziv Med. 2021;32(6):271-279. Go to original source...
  2. Blair M, Côté JM, Cotter A, Lynch B, Redahan L, Murray PT. Nephrotoxicity from Vancomycin Combined with Piperacillin­‑Tazobactam: A Comprehensive Review. Am J Nephrol. 2021;52:85-97. doi: 10.1159/000513742. Go to original source... Go to PubMed...
  3. Li H, Yang Q, Gui M, Ding L, Yang L, Sun H, et al. Changes of renal transporters in the kinetic process of VCM­‑induced nephrotoxicity in mice. Toxicol Res (Camb). 2021;10(4):687-695. doi:10.1093/toxres/tfab048 Go to original source... Go to PubMed...
  4. Miano TA, Hennessy S, Yang W, Dunn TG, Weisman AR, Oniyide O, et al. Association of vancomycin plus piperacillin-tazobactam with early changes in creatinine versus cystatin C in critically ill adults: a prospective cohort study. Intensive Care Medicine. 2022;48(9):1144-1155. Go to original source... Go to PubMed...
  5. Hagel S, Bach F, Brenner T, Bracht H, Brinkmann A, Annecke T, et al. Effect of therapeutic drug monitoring­‑based dose optimization of piperacillin/tazobactam on sepsis­‑related organ dysfunction in patients with sepsis: a randomized controlled trial. Intensive Care Med. 2022;48(3):311-321. Go to original source... Go to PubMed...
  6. Chawla L. Permissive azotemia during acute kidney injury enables more rapid renal recovery and less renal fibrosis: a hypothesis and clinical development plan. Critical Care. 2022;26(1):116. Go to original source... Go to PubMed...
  7. Wald R, Beaubien­‑Souligny W, Chanchlani R, Clark EG, Neyra JA, Ostermann M, et al. Delivering optimal renal replacement therapy to critically ill patients with acute kidney injury. Intensive Care Med. 2022;48(10):1368-1381. Go to original source... Go to PubMed...
  8. Murugan R, Bellomo R, Palevsky PM, Kellum JA. Ultrafiltration in critically ill patients treated with kidney replacement therapy. Nat Rev Nephrol. 2021;17(4):262-276. Go to original source... Go to PubMed...
  9. Murugan R, Kerti SJ, Chang CCH, Gallagher M, Neto AS, Clermont G, et al. Association between Net Ultrafiltration Rate and Renal Recovery among Critically Ill Adults with Acute Kidney Injury Receiving Continuous Renal Replacement Therapy: An Observational Cohort Study. Blood Purif. 2021:1-13. doi: 10.1159/000517281. Go to original source... Go to PubMed...
  10. Fah M, Van Althuis LE, Ohnuma T, Winthrop HM, Haines KL, Williams D, et al. Micronutrient deficiencies in critically ill patients receiving continuous renal replacement therapy. Clin Nutr ESPEN. 2022;50:247-254. Go to original source... Go to PubMed...
  11. Thompson Bastin ML, Stromberg AJ, Nerusu SN, Liu LJ, Mayer KP, Liu KD, et al. Association of Phosphate­‑Containing versus Phosphate­‑Free Solutions on Ventilator Days in Patients Requiring Continuous Kidney Replacement Therapy. CJASN. 2022;17(5)634-642. Go to original source... Go to PubMed...
  12. Kotfis K, van Diem­‑Zaal I, Roberson SW, Sietnicki M, van den Boogaard M, Shehabi Y, et al. The future of intensive care: delirium should no longer be an issue. Crit Care. 2022;26(1):200. Go to original source... Go to PubMed...
  13. Sansom B, Sriram S, Presneill J, Bellomo R. Low Blood Flow Continuous Veno­‑Venous Haemodialysis Compared with Higher Blood Flow Continuous Veno­‑Venous Haemodiafiltration: Effect on Alarm Rates, Filter Life, and Azotaemic Control. Blood Purif. 2022;51:130-137. doi: 10.1159/000516146 Go to original source... Go to PubMed...
  14. Supady A, Zahn T, Kuhl M, Maier S, Benk Ch, Kaier K, et al. Cytokine adsorption in patients with post­‑cardiac arrest syndrome after extracorporeal cardiopulmonary resuscitation (CYTER) - A single­‑centre, open­‑label, randomised, controlled trial, Resuscitation. 2022;173:169-178. Go to original source... Go to PubMed...
  15. Diab M, Lehman T, Bothe W, Platzer S, Wendt D, Deppe AC, et al. Cytokine Hemoadsorption During Cardiac Surgery Versus Standard Surgical Care for Infective Endocarditis (REMOVE): Results From a Multicenter Randomized Controlled Trial. Circulation. 2022;145:959-968. Go to original source... Go to PubMed...
  16. Stockmann H, Thelen P, Stroben F, Pigorsch M, Keller T, Krannich A, et al. Cytosorb Rescue for COVID-19 Patients With Vasoplegic Shock and Multiple Organ Failure: A Prospective, Open­‑Label, Randomized Controlled Pilot Study. Crit Care Med. 2022;50(6):964-976. Go to original source... Go to PubMed...




Anesteziologie a intenzivní medicína

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.